Innoviva (INVA) Intangibles (2013 - 2026)
Innoviva (INVA) posted Intangibles of $175.6 million for Q1 2026, down 3.6% on a QoQ basis from $182.2 million in Q4 2025, and down 32.9% year-over-year from $261.7 million in Q1 2025.
Innoviva (INVA) Intangibles (2013 - 2026) Analysis & Trends
Innoviva's Intangibles history runs 7 years deep, the most recent figure standing at $175.6 million for Q1 2026.
- Quarterly Intangibles fell 32.9% year-over-year to $175.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $175.6 million (down 32.9% YoY) and the FY2025 annual result came in at $182.2 million, down 30.4% from the prior year.
- Intangibles was $175.6 million for Q1 2026 at Innoviva, down from $182.2 million in the prior quarter.
- Across five years, Intangibles topped out at $261.7 million in Q4 2024 and bottomed at $105.0 million in Q1 2022.
- A 5-year average of $219.1 million and a median of $243.4 million in 2023 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2023 — Intangibles soared 136.49% — and 2026, when it sank 32.9%.
- Innoviva's Intangibles stood at $258.5 million in 2022, then retreated by 10.9% to $230.3 million in 2023, then grew by 13.62% to $261.7 million in 2024, then slumped by 30.4% to $182.2 million in 2025, then declined by 3.6% to $175.6 million in 2026.
- Business Quant data shows INVA's Intangibles at $175.6 million in Q1 2026, $182.2 million in Q4 2025, and $188.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 11,640.44 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 61.68 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.92 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 55.80 Mn |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | 175.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 175.60 Mn |
| Dec 31, 2025 | 182.16 Mn |
| Sep 30, 2025 | 188.79 Mn |
| Jun 30, 2025 | 195.41 Mn |
| Mar 31, 2025 | 261.70 Mn |
| Dec 31, 2024 | 261.70 Mn |
| Sep 30, 2024 | 257.70 Mn |
| Jun 30, 2024 | 257.70 Mn |
| Mar 31, 2024 | 257.70 Mn |
| Dec 31, 2023 | 230.34 Mn |
| Sep 30, 2023 | 236.85 Mn |
| Jun 30, 2023 | 243.36 Mn |
| Mar 31, 2023 | 248.31 Mn |
| Dec 31, 2022 | 258.50 Mn |
| Sep 30, 2022 | 258.49 Mn |
| Jun 30, 2022 | 105.00 Mn |
| Mar 31, 2022 | 105.00 Mn |
| Sep 30, 2014 | 211.65 Mn |
| Jun 30, 2014 | 194.88 Mn |
| Mar 31, 2014 | 137.48 Mn |